Anuh Pharma Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018

ANUHPHR · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

+6.7%1-day move

₹73.55

prior close

₹75.40

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

+0.5+1.1+0.4+0.4+6.7+8.7+6.1+9.8+12.7+10.5+10.3+14.1+2.7+7.4

Up moveDown movePending

AI summary

Anuh Pharma Limited has filed a compliance certificate under SEBI Regulation 74(5) for the quarter ending 31st March 2026. The certificate was issued by Bigshare Services Private Limited, the company's Registrar and Share Transfer Agent (RTA). The filing confirms that no dematerialisation requests for equity shares were received during the period 1st January 2026 to 31st March 2026. This is a mandatory quarterly filing under SEBI regulations that requires RTAs to confirm compliance with dematerialisation request processing timelines. The company submitted this filing on 7th April 2026, within the prescribed deadline.

Likely market impact

This is a routine regulatory compliance filing with no material impact on shareholders or stock price. The nil-report confirms normal operations with no unusual dematerialisation activity during Q1 2026.